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Objectives: We sought to analyze the collected worldwide experience with
use of snorkel/chimney endovascular aneurysm repair (EVAR) for complex
abdominal aneurysm treatment.
Background: EVAR has largely replaced open surgery worldwide for
anatomically suitable aortic aneurysms. Lack of availability of fenestrated
and branched devices has encouraged an alternative strategy utilizing parallel
or snorkel/chimney grafts (ch-EVAR).
Methods: Clinical and radiographic information was retrospectively reviewed
and analyzed on 517 patients treated by ch-EVAR from 2008 from 2014 by
prearranged defined and documented protocols.
Results: A total of 119 patients in US centers and 398 in European centers
were treated during the study period. US centers preferentially used Zenith
stent-grafts (54.2%) and European centers Endurant stent-grafts (62.2%) for
the main body component. Overall 898 chimney grafts (49.2% balloon ex-
pandable, 39.6% self-expanding covered stents, and 11.2% balloon expandable
bare metal stents) were placed in 692 renal arteries, 156 superior mesenteric
arteries (SMA), and 50 celiac arteries. At a mean follow-up of 17.1 months
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(range: 1–70 months), primary patency was 94%, with secondary patency of
95.3%. Overall survival of patients in this high-risk cohort for open repair at
latest follow-up was 79%.
Conclusions: This global experience represents the largest series in the ch-
EVAR literature and demonstrates comparable outcomes to those in published
reports of branched/fenestrated devices, suggesting the appropriateness of
broader applicability and the need for continued careful surveillance. These
results support ch-EVAR as a valid off-the-shelf and immediately available
alternative in the treatment of complex abdominal EVAR and provide impetus
for the standardization of these techniques in the future.
Keywords: abdominal aortic aneurysm, endovascular, fenestrated, thoracoab-
dominal, vascular
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T he snorkel/chimney technique is an endovascular therapeuticmodality for branch revascularization in complex aortic patholo-
gies that has gained increasing popularity since the first publications
in 2003 and 2007.1,2 These techniques have emerged from the basic
idea of creating a “snorkel/chimney” conduit from available off-the-
shelf stents deployed into target visceral branches from a parallel
course adjacent to the main intra-aortic stent-graft. Initially proposed
as a bailout technique for inadvertent coverage or emergent situations,
this strategy has since been employed electively in juxta- or pararenal
cases with the goal to preserve or restore normal blood flow into the
involved branch or branches.1–10
The current body of published literature on snorkel/chimney
endovascular aneurysm repair (ch-EVAR) consists mainly of case re-
ports and single center series with limited numbers of patients and
follow-up. Furthermore, the majority of patients were being treated
for a wide variety of aortic pathologies using nonstandardized off-
the-shelf devices and follow-up protocols. As a result, critics of the
snorkel/chimney approach as a mainstream strategy claim that it re-
mains difficult to obtain a clear picture of ch-EVAR outcomes and
its potential applications. With fenestrated/branched solutions slowly
being approved by the Food and Drug Administration as a purpose-
specific and on-label solution to complex EVAR, concerns with ch-
EVAR regarding overall technical success, gutter-related type Ia en-
doleaks, chimney stent patency, long-term renal dysfunction, and
ch-EVAR durability make this approach an oft-debated treatment
strategy. The purpose of this study was to collect and analyze a large
sample of the world experience with ch-EVAR from centers with sig-
nificant experience and standardized protocols for operative strategy
and follow-up to provide the latest evidence regarding this treatment
option for complex abdominal aortic aneurysms.
METHODS
The study was conducted to evaluate the PERformance of the
chImney technique for the treatment ofComplex aortic pathoLogiES
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(PERICLES registry). It complied with the principles of the Decla-
ration of Helsinki and the data collection, and acquisition was ap-
proved by the local ethics committee and respective institutional
review boards from the individual sites participating in the reg-
istry. A retrospective chart and imaging review was then performed
and entered in a de-identified fashion into a central data repository.
After a systematic review of the literature had been published as
to early results of ch-EVAR,9 centers having reported case series
were contacted and asked to participate in the PERICLES registry.
Participating centers (see Supplemental Digital Content Appendix,
available at http://links.lww.com/SLA/A836) were required to have
treated at least 10 patients with complex aortic pathologies by the
snorkel/chimney technique. All commercially available abdominal
endografts in different combinations with chimney grafts were in-
cluded in the present study. Patients with thoracic aneurysms, aortic
dissections, or extensive thoracoabdominal aneurysms with involve-
ment of the supradiaphragmatic thoracic segment were excluded.
Clinical and radiological data were reviewed and analyzed on the
basis of protocols with predefined parameters as to comorbidities,
classification, and description of the various pathologies, intraopera-
tive variables, and relevant clinical outcome variables.
Indications
All patients considered candidates for ch-EVAR at each insti-
tution were deemed to be high-risk candidates for open surgical repair.
This category often included patients with several cardiovascular or
anatomic comorbidities such as active chronic obstructive pulmonary
disease, poorly controlled congestive heart failure, symptomatic coro-
nary artery occlusive disease, American Society of Anesthesiologists
score of 3 or more, previous myocardial infarction, coronary stent
or bypass, and/or prior open abdominal aortic repair. In 3 of 13 par-
ticipating centers, fenestrated/branched endografts (f-EVAR) were
available, and the included ch-EVAR cases in this registry were based
on surgeon preference, the need for urgent treatment, and/or anatomi-
cal unsuitability for f-EVAR such as presence of severe angulation of
the neck or severe calcification, and stenosis or angulation of the iliac
vessels. Because the PERICLES registry was an individual institution
registry data collection, details about outcomes stemming from other
concurrent strategies at each individual center were not obtained.
Definitions
Complex aortic anatomy has some heterogeneity, and we de-
fined juxtarenal pathologies to include degenerative aneurysms or
penetrating atherosclerotic ulcers up to the level of renal arteries, type
Ia endoleaks after standard EVAR, and para-anastomotic aneurysms
after previous open aortic repair. Pararenal pathology was defined as
aneurysm dilation up to the level of the superior mesenteric artery.
There was a small number of type IV thoracoabdominal aneurysms
included in the PERICLES with slight dilation at the level of the SMA
that did not extend to the diaphragm.
Patients’ risk factors and demographics and outcomes were
collected and adhered to the reporting standards of the Society for
Vascular Surgery.11 Chimney graft-related reinterventions were de-
fined as secondary procedures performed to treat high-grade stenosis
(>70%) confirmed by angiography, occlusions of the chimney grafts,
or endoleaks around chimney grafts, requiring additional proximal
treatment. Chimney graft patency was defined as the absence of oc-
clusion on postoperative imaging and perfusion of the target organ
(most often the kidney). Technical success was defined as success-
fully completed ch-EVAR (patent endograft and involved target ves-
sels without evidence of type I or III endoleak on the basis of the
classification from Pecoraro et al).10
Endpoints
Primary endpoints included aneurysm sac diameter regres-
sion, chimney graft patency, and freedom from endoleak. Secondary
endpoints included all-cause mortality, aneurysm-related mortality,
chimney graft-related reinterventions, and renal function. Follow-up
data included events during the initial hospitalization and the postop-
erative period up to the date of the last available radiological imaging.
Data on clinical status, duplex ultrasound imaging, and contrast com-
puted tomographic scan/magnetic resonance image were reviewed
and collected for each patient.
Acute and Chronic Renal Function Changes
For acute renal deterioration, we utilized the consensus def-
inition of acute kidney injury (AKI) defined by the RIFLE system,
proposed by the Acute Dialysis Quality Initiative group, which stages
AKI into 5 grades: risk (R), injury (I), failure (F), loss (L), and end
stage (E).12 In detail, Risk was defined as a 1.5x relative increase in
serum creatinine from baseline or a decrease of glomerular filtration
rate (GFR) more than 25% compared with the baseline. Injury was
defined as a 2x increase in serum creatinine or GFR decrease more
than 50%; failure 3x increase in serum creatinine or GFR decrease
more than 75%. Loss of kidney function is for more than 4 weeks
and end-stage kidney disease was defined as compete loss of kidney
function for more than 3 months.
For chronic real deterioration, the widely employed chronic
kidney disease (CKD) staging system developed by the National Kid-
ney Foundation was used with CKD stages on the basis of estimated
GFR. Stage 1 was defined as GFR more than 90 mL/min/1.73 m2 and
stage 2 as mildly reduced kidney function with a GFR value between
60 and 89. Stage 3A and 3B reflect moderately reduced kidney func-
tion, with a GFR between 45 and 59 (stage 3A) or 30 and 44 (stage
3B). Stage 4 was associated with severely reduced kidney function
(GFR 15–29) and stage 5 was defined as very severe or end-stage
kidney failure with a GFR of less than 15.
Statistical Analysis
Descriptive statistics were used to assess study demograph-
ics, comorbidities, and outcome variables as appropriate. Student t
test and Pearson χ 2 tests were used to analyze relationships between
continuous and categorical variables, respectively. Comparison of
pre-and postoperative ch-EVAR maximum aneurysm diameters was
performed with the paired t test as appropriate. Freedom from renal
decline was evaluated using Kaplan-Meier methods. A P value of
less than 0.05 was considered statistically significant for all analy-
ses. Statistical analysis was performed using STATA 12.0 software
(StataCorp LP, College Station, TX).
RESULTS
A total of 119 patients were treated at participating US centers
and 398 in Europe from 2008 to 2014. US centers used Zenith stent-
grafts (Cook Medical, Bloomington, IN) in the majority of cases
(54.2%) whereas the Endurant stent-graft (Medtronic, Santa Rosa,
CA) was most commonly used at the European centers (62.2%). Over-
all, Endurant was used in 49.5% (n = 260 patients), and Zenith in
17.3% (n = 91). Tables 1, 2, and 3 summarize the treated pathologies,
cohort demographics, anatomic characteristics, relevant intraopera-
tive variables, and the abdominal and chimney devices used.
In all, 898 target aortic branch vessels were revascularized
using chimney grafts. The mean number of chimney grafts placed
was 1.73 per patient, with 692 renal chimneys, 156 SMA chimneys,
and 50 celiac chimneys inserted. Of these, 49.2% (n = 442) were
balloon-expandable covered stents [Advanta (iCAST) V12, Maquet,
New Hudson, NJ] and 39.6% (n = 355) were self-expanding covered
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TABLE 1. Aortic Pathologies Treated With the
Snorkel/Chimney Technique
Total patients 517
European centers (N = 9) 398
United States centers (N = 4) 119
Disease, n (%)
Degenerating aneurysm 404 (78.1)
Penetrating ulcer 12 (2.3)
Type 1a endoleak from prior EVAR 45 (8.7)
Para-anastomotic aneurysm from prior open AAA repair 43 (8.3)
Intramural hematoma/type B dissection 13 (2.5%)
Classification, n (%)
Juxtarenal AAA 360 (69.6)
Suprarenal AAA 129 (25.0)
Type IV TAAA 28 (5.4)
Clinical status, n (%)
Asymptomatic 415 (80.3)
Symptomatic 52 (10.0)
Rapidly growing 21 (4.1)
Rupture 29 (5.6)
AAA indicates abdominal aortic aneurysm; EVAR, endovascular aneurysm repair;
TAA, thoraco-abdominal aneurysm.
TABLE 2. Patient Characteristics and Demographics
Age, mean ± SD (range), yr 75.2 ± 7.8 (48–93)
Sex
Male (%) 83.7
Female (%) 16.3
ASA class, n (%)
I 0 (0)
II 18 (3.5)
III 293 (56.6)
IV 2404 (39.5)
V 2 (0.4)
Diabetes 112 (21.8)
Hyperlipidemia 315 (61.1)
Hypertension 455 (88.2)
CAD 276 (53.5)
COPD 216 (42.0)
PAD 85 (81.2)
Smoking history (%)
None 182 (36.5)
Quit >6 mo 214 (42.9)
Quit <6 mo 19 (3.8)
Current smoker 84 (16.8)
CHF 186 (40.1)
Chronic renal insufficiency (GFR <60) 173 (39.7)
Hemodialysis 11 (2.5)
CAD indicates coronary artery disease; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; PAD, peripheral arterial disease.
stents (Viabahn, Gore Medical, Flagstaff, AZ). Balloon-expandable
bare-metal stents were used as the primary chimney stent in 11.2% of
the cases (n = 101). Bare-metal nitinol stents were used to reline the
inside of a covered chimney stent in 25.4% (220/898) of the cases,
most often the Viabahn.
The mean preoperative diameter of the juxtarenal aneurysms
treated was 65.9 ± 16.5 mm (range: 48–135 mm), with a mean pre-
operative proximal neck length of 4.8 ± 7.4 mm (range: 0–13 mm),
making them unsuitable for traditional EVAR. The snorkel/chimney
strategy increased the theoretical neck/seal length to 21.1 ± 12.7 mm
(range: 9–43 mm). Intraoperative characteristics are summarized in
Table 3. A type Ia endoleak was noted intraoperatively in 41 patients
TABLE 3. Juxtarenal Aneurysm Anatomic Characteristics,
Aortic and Branch Stent-grafts, and Intraoperative
Variables
Preoperative anatomy
Maximum aneurysm diameter
(mm), mean ± SD
65.9 ± 216.5
Minimum aneurysm diameter
(mm), mean ± SD
55.0 ± 17.2
Infrarenal neck diameter (mm),
mean ± SD
26.4 ± 4.8
Infrarenal neck length (mm), mean
± SD
4.8 ± 7.4
Snorkel/chimney neck length,
mean ± SD
21.1 ± 12.7
Device, n (%)
Endurant 260 (49.5)
Zenith 91 (17.3)
Excluder 75 (14.3)
Gore TAG 28 (5.3)
Jotec 17 (3.2)
Zenith TX2 11 (2.1)
Valiant 31 (6.0)
Talent 4 (0.7)
Total chimney grafts, n 898
Right renal 342
Left renal 316
Accessory renal 34
SMA 156
Celiac 50
Types of chimney grafts (%)
Balloon-expandable covered 442 (49.2)
Self-expanding covered 355 (39.6)
Balloon-expandable bare metal 101 (11.2)
Use of bare metal nitinol stents
“endolining” (as percentage of
cohort)
220 (25.4)
Intraoperative variables
Operative time (min), mean ± SD 233.0 ± 98.7
Fluoroscopy time (min), mean ±
SD
60.83 ± 38.6
Contrast volume (mL), mean ± SD 162.4 ± 59.6
SMA indicates superior mesenteric artery.
(7.9%). Corrective treatment consisted of kissing-balloon dilatations
of the aortic stent-graft and chimney graft in 21, and additional prox-
imal aortic cuff placement in 5 patients. Fifteen patients (2.9%) ex-
hibited a persistent type Ia endoleak despite attempted corrective
measures. Thus, technical success was achieved perioperatively in
502 of the 517 cases (97.1%).
The 30-day mortality was 4.9% (25/517) for the entire cohort.
Of note, 29 patients had ch-EVAR for ruptures, with a 30-day mortal-
ity of 24.1% (n = 7), making the elective 30-day mortality rate 3.7%
(18/488). Late mortality was 15.5% at longest follow-up (80/517).
Four procedure-related deaths were reported (0.7%). Three were due
to bowel ischemia and 1 related to graft infection. Otherwise, heart
failure (n = 23) and cancer (n = 11) were the main unrelated diseases
leading to mortality during follow-up. Other causes of death unrelated
to the aortic pathology or procedures were pneumonia and sepsis
(n = 13) and “poor general health status” (n = 7). The estimated
patient survival was 91.3% (range: 88.3%–93.6%), 84.9% (range:
80.1%–88.0%), 77.2% (range: 72.2%–81.5%), and 74.9% (range:
56.1%–79.4%) at 6 months, 1 year, 2 years, and 3 years, respectively
(Fig. 1). No patient developed spinal cord ischemia from any eti-
ology. Nine patients (1.7%) had an embolic stroke judged to have
been related to the upper-extremity arterial access. All but 1 of these
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FIGURE 1. Overall survival rate of the patients treated with
snorkel/chimney techniques at latest follow-up.
patients had placement of multiple chimney grafts. Thirty-day mor-
bidity included postoperative access-site related issues requiring rein-
tervention for occlusion or pseudoaneurysm in 10 (1.9%) patients,
pneumonia in 16 (3.1%) patients, myocardial infarction in 11 (2.1%)
patients, and graft infection in 1 (0.2%) patient.
Computed tomographic follow-up imaging showed subsequent
resolution of the intraoperative type Ia endoleak in all but 2 cases
(0.4%), both requiring open surgical conversion with explantation of
the aortic and chimney devices. Three other cases (0.6%) in whom
a late-onset type Ia endoleak was detected at 6-month computed to-
mography were all treated successfully by endovascular means such
as “neck lengthening” and placement of additional chimneys. These
endoleaks were judged to be gutter-related endoleaks and were elim-
inated by the successful “neck lengthening” with creation of a longer
landing or seal zone. Interestingly, there seemed to be a trend toward
the use of a balloon-expandable covered stent having 2-fold reduction
in type Ia endoleaks than self-expanding covered stents (P = 0.018).
At a mean imaging follow-up of 17.1 ± 8.2 months (range:
1–70 months), mean abdominal aortic aneurysm diameter had de-
creased to 61.2 ± 19.7 mm (P < 0.001 compared with preoperative),
with an individual mean sac regression of 4.4 mm ± 13.1 mm. Over-
all primary chimney-graft patency was 94.1%. This was not affected
whether a balloon-expandable or self-expanding covered stent was
used (P = 0.440). As shown in Figure 2, patency was estimated to be
94.9%, 91.8%, 89.2%, and 87.0% at 6 months, 1 year, 2 years, and
3 years, respectively. Late open surgical conversion was necessary
due to infection (n = 2), persistent type Ia endoleak (n = 2), and
endotension with aneurysm enlargement (n = 1). No patient in this
registry presented with aortic rupture at latest follow-up. A secondary
procedure was also required to attempt reopening occluded chimney
grafts (n = 13) and to seal persistent type II endoleaks leading to
aneurysm growth of 5 mm or more (n = 5) or a type III endoleak
(n = 3). Overall success of these secondary procedures for their
intended purpose was 62%, but with no additional morbidity or mor-
tality. This gave an overall second intervention rate of 6.6% at latest
follow-up.
Table 4 presents an overview of the postoperative changes in re-
nal function. During the immediate postoperative period, 67 (17.5%)
patients experienced some form of AKI by RIFLE criteria. However,
FIGURE 2. Kaplan-Meier estimates showing the patency of
snorkel/chimney grafts at latest follow-up.
TABLE 4. Overview of Renal Outcomes
Preoperative renal disease, n (%) 435 total reporting
CKD stage 1 or 2 257 (59.0)
CKD stage 3 158 (36.3)
CKD stage 4 16 (3.7)
CKD stage 5 4 (0.9)
Postoperative acute kidney injury 381 total reporting 67
Risk 40 (59.7)
Injury 9 (13.4)
Failure 10 (14.9)
Loss/end-stage 8 (11.9)
Long-term postoperative renal
disease
381 total reporting
CKD stage 1 or 2 193 (50.6)
CKD stage 3 149 (39.1)
CKD stage 4 27 (7.1)
CKD stage 5 12 (3.1)
Change in CKD stage
−2 Stage 2 (0.5)
−1 Stage 32 (8.4)
0 Stage 263 (69.2)
+1 stage 66 (17.4)
+2 Stage 12 (3.2)
+3 Stage 5 (1.3)
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the majority of these patients (n = 40, 59.7%) showed only the lowest
grade of acute renal function deterioration. Only 8 of the 67 patients
(11.9%, or 1.5% of the entire cohort) who developed AKI required
either temporary or permanent dialysis. In midterm follow-up, CKD
was found in 83 patients with declining renal function, of whom 66
patients experienced only a 1-stage worsening by CKD level. Twelve
(3.2%) and 5 (1.3%) patients experienced a 2- or 3-stage worsening
of renal function based on CKD, respectively. When comparing the
prevalence of end-stage 5 CKDs pre- and postoperatively, there was
an increase from 0.9% (n = 4) to 3.1% (n = 12) of patients with end-
stage renal failure, requiring long-term hemodialysis. Interestingly,
34 (8.9%) patients experienced a clinically significant improvement
in kidney function caused probably by treatment of coexisting renal
artery stenoses by the chimney grafts. Five patients (1%) with oc-
clusion of renal chimney grafts suffered significant deterioration of
renal function from CKD stage 1/2 to stage 5 and became dialysis-
dependent. The majority of patients in the cohort (69.2%) experienced
no change in CKD stage.
DISCUSSION
The PERICLES registry represents the largest collection of ch-
EVAR procedures and patients so far reported in the global literature,
reflecting the “real-world” clinical practice involving management
of 517 patients in 13 centers with complex juxtarenal and pararenal
aortic pathologies. The degree of sac regression postoperatively, the
rate of primary patency of these chimney grafts, and the relatively
low incidence of type I endoleaks requiring reintervention highlight
the value of these techniques and the fact that their wider use may
well be warranted.
From the inception and initial descriptions of the snorkel/
chimney strategy, the potential disadvantages and problems have been
emphasized with particular attention to the inevitable formation of
gutters between the chimney and main endografts and how these
could be the cause of type Ia endoleaks. The stent-grafts were never
designed to theoretically mold around each other to create a seal, but
based on the numerous small case series in the literature, the pro-
cedure has worked, although most authors recommend caution until
larger series are published.13 This current study with a wide variety of
operators but a generally consistent operative technique reveals that
formation of a persistent or new-onset postoperative type Ia endoleaks
is rare as long as a sufficiently long (we suggest 20 mm) proximal
landing zone can be created (Figs. 3A–C). The majority of type Ia
endoleaks detected intraoperatively resolved with prolonged kissing-
balloon dilation between the aortic and chimney stent-grafts or addi-
tional cuff placement. Should the endoleak persist, close follow-up
and monitoring with frequent imaging are required to exclude signifi-
cant enlargement of the aneurysm sac. If this occurs, further measures
such as “neck lengthening” by proximal extensions are employed to
create a sufficient sealing zone or even surgical conversion. Future
studies are ongoing to try to identify the best combinations of aor-
tic and branch stent-grafts to minimize these theoretical gutter con-
cerns, and this could lower the incidence of type Ia endoleaks even
further.14
The present global experience highlights the successful use of
off-the-shelf devices used in a parallel graft strategy to create total en-
dovascular solutions for treatment of complex pararenal pathologies
involving essential branch arteries. The main alternative strategy to
compare our results against is the use of fenestrated grafts for similar
lesions. Such fenestrated endografts have been used for many years
worldwide, but their wide spread use is relatively early in the United
States. Although a direct comparison in a randomized trial will prob-
ably never be done, comparison of this current study results with the
published literature on fenestrated endografts is important.15 Avail-
able data comparing the techniques before this current series have
shown no statistically significant difference between ch-EVAR and
fenestrated EVAR (f-EVAR) with regard to technical success, target
branch vessel patency, early mortality, type I endoleak, postoperative
renal dysfunction, or need for secondary intervention.16 Still, critics
of the ch-EVAR strategy claim that the data are short-term and small
in number.
With regard to overall mortality rates after f-EVAR, a pooled
30-day mortality of 2.1% was calculated noted in a recent systematic
review17 that included 9 studies encompassing 629 patients, compar-
ing favorably with our current ch-EVAR study with its 30-day mortal-
ity of 4.9% (3.7% if ruptured ch-EVAR was excluded). In an earlier
meta-analysis of published reports of ch-EVAR18 up to 2012, an over-
all pooled 30-day mortality of 3.4% was noted in 14 studies covering
176 patients. All of these results are acceptable as most patients with
juxtarenal aneurysms have significant comorbid medical conditions
and the postoperative mortality is often linked to cardiopulmonary
issues. Interestingly, when f-EVAR has been compared by propensity
matching to series of open surgical repair for juxtarenal aneurysms,
FIGURE 3. A, Coronal section of juxtarenal aortic aneurysm with no neck. Aneurysm thrombus comes right up to left renal
artery. Arrows point to each renal artery to be revascularized. B, Intraoperative angiogram showing the balloon molding of the
snorkel/chimney grafts (arrows) adjacent to the main body aortic graft. Note that the fabric of the renal grafts is above the aortic
graft. C, One-year follow-up computed tomographic-A reconstruction with arrows pointing at snorkel/chimney grafts in good
position without kinking and excluding flow into the aneurysm sac (balloon-expandable covered stent Maquet iCast as chimney
graft and Cook Zenith bifurcated endograft as abdominal device).
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the mortality for f-EVAR is as high as 9.5%, indicating that there is
a range of mortality for f-EVAR depending on center experience.19
In the only comparison of ch-EVAR with open repair at the
same institution, the University of Florida group found in matched
anatomic patients that even with worse baseline renal and pulmonary
function, no difference in 30-day mortality was observed between
the 2 treatment groups (4.8% in each).20 Significant reduction in
estimated blood loss, transfusion requirements, and length of stay
were also noted in the ch-EVAR group. The current study was not
meant to be compared with open repair, because the high level of
comorbidities made most of the patients in this registry noncandidates
for open repair at their respective institutions.
Reinterventions and branch vessel patency are likely the main
durability issues of any endovascular treatment, and particularly for
ch-EVAR and f-EVAR, these issues are related to type Ia endoleaks
and branch patency. Extremely durable results have been published by
the world’s most experienced f-EVAR center, the Cleveland Clinic,
and comparison of these results with those of the current study is
worthwhile.21 In the Cleveland Clinic article, excellent long-term
durability of endovascular repair in 650 patients (1679 target ves-
sels) undergoing abdominal aortic aneurysm repair with branched or
fenestrated devices between 2001 and 2010 is reported. The 30-day, 1-
year, and 5-year freedom from branch reintervention was 98%, 94%,
and 84%, respectively. These numbers from this single institution are
better than those that our current PERICLES registry is reporting.
However, their f-EVAR results are not corroborated by meta-analyses
of published reports when more centers are included, suggesting that
“real-world” data cannot match those of the most experienced opera-
tors. The earlier mentioned meta-analysis of f-EVAR that included 9
studies encompassing 629 patients and a total of 1622 target vessels
documented a pooled technical success rate of 90.7% and an esti-
mated reintervention rate of 17.8% during a follow-up period of 15 to
25 months.17 More importantly, branch vessel patency was found to
be 93.2%, renal function decline 22.2%, and all-cause morality 16%
at the 15- to 25-month follow-up range, numbers nearly identical to
our results from the PERICLES registry.
In a more recent systematic review and meta-analysis of f-
EVAR,22 the outcomes of 12 studies involving a total of 776 patients
and more than 1728 target vessels calculated a pooled estimate for
30-day mortality of 2.5%, technical success of 92.8%, a short-term
12-month type I endoleak rate of 7.9%, target vessel patency of
94.5%, and a secondary intervention rate of 17.6%. More than 70%
of the reinterventions occurred during the first year after f-EVAR, and
loss of renal artery patency was the leading reason for reintervention
(24.1%). These pooled results clearly highlight the learning curve
necessary for f-EVAR or any complex EVAR strategy. They also
emphasize that the results from the most experienced centers may not
be achievable everywhere.15
There are several limitations to our current study, namely, its
retrospective nature and the inability as in standard Food and Drug
Administration approval clinical trials to capture all the relevant pre-
and postoperative parameters to determine risk factors and clinical
patterns for complications. The registry is also made up of self-
reported data, and although we tried to standardize and collect data
in a uniform manner, some are missing and there is some heterogene-
ity in the types of patients treated. Although the general technique of
brachial access and caudally directed parallel stent-grafting was simi-
larly performed, a standardized technique and sequence of steps were
not strictly adhered to and the selection criteria for ch-EVAR var-
ied. In addition, the lack of standardization of the technique provides
us with a mixture of different aortic endografts and chimney grafts.
We believe, though that this may constitute a positive aspect of our
study, as the general parallel graft strategy seems to be non–device-
dependent, because it works successfully with different types of grafts
and snorkel/chimney stents and in varying experienced operators. Al-
though there is a suggestion that balloon-expandable–covered stents
may have a lower type Ia endoleak rate than self-expanding covered
stents in our registry, selection bias could account for this issue as
more tortuous anatomy often forces the use of self-expanding cov-
ered stents. Finally, these are still only midterm results. Although
some small series with even longer-term follow-up have raised con-
cerns about the stability of the parallel endograft strategy for complex
aneurysms,23 longer periods of follow-up observation of our patients
in this registry are warranted.
CONCLUSIONS
We present the largest collection to date of the snorkel/chimney
EVAR strategy for the treatment of juxtarenal and pararenal pathol-
ogy. Technical success, early mortality, survival, freedom from
aneurysm-related death, midterm branch patency and durability, en-
doleaks, and secondary interventions are all reported and are com-
parable with published results from series of fenestrated grafts. We,
therefore, believe that this parallel graft strategy should be in the
armamentarium of surgeon treating complex aortic lesions, because
it provides an immediate off-the-shelf solution that is safe, effective,
and durable in the midterm. We view this strategy as complementary
to fenestrated and branched devices, with numerous advantages and
disadvantages depending on the anatomy and presentation of the pa-
tient with a complex aneurysm. Although close attention to technical
details, device selection, and careful planning to create a sufficient
seal zone of at least 20 mm is necessary to achieve good outcomes,
the present results indicate that snorkel/chimney EVAR and other
parallel graft techniques are a viable treatment method that deserves
further study and wider usage.
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DISCUSSANTS
K.C. Kent (Madison, WI):
This is a great study and a tremendous effort at analyzing the
outcomes of a new and innovative technology. Surgeons and all inter-
ventionalists are often quick to embrace new technology but less effi-
cient in studying the outcomes in a scientific manner. You are clearly
the exception. Although we hail randomized comparative studies as
the Holy Grail, registries are often the more practical and expeditious
way to accomplish this evaluation. You are to be commended in creat-
ing the PERICLES registry, which is a large and comprehensive effort
in cataloging the world’s experience with snorkel/chimney grafts. The
findings, which include 517 patients from 13 centers, are quite posi-
tive for a very complex group of patients. Overall, 30-day mortality
was 3.7% for elective interventions, and the long-term mortality is as
would be expected for this ill group of patients. The complications
that one would worry about with this type of intervention include type
1 endoleaks (the number was small and there were only 2 conversions
for type 1 leaks) and complications related to the treated vessels: re-
nal failure (about 3% of patients progressed to dialysis), mesenteric
ischemia (3 patients total), and ischemic stroke related to the brachial
approach (<2%). Thus, the overall outcomes are quite impressive. It
is important for the nonvascular surgeons in the audience to realize
that there is a competing technology for pararenal and mesenteric
aneurysms—grafts that have fenestrations or branches.
The ultimate question is how do the outcomes with
snorkel/chimney grafts compare not so much with open surgery but
to those of the competing technology.
I have a several questions:
1. For the renal and mesenteric vessels, a variety of conduits were
used. Covered balloon-expandable stents covered self-expanding
stents and noncovered stents. Are there any data to show that 1
approach is more effective than another? What conduit do you
use?
2. Are there any data to suggest that 1 type of endograft is more
advantageous than another? Is 1 graft more likely to conform
around the conduits? Did you perform a comparative analysis with
your data?
3. You comment in the manuscript that type 1 endoleaks are rare as
long as the landing zone is at least 20 mm. Do you have data to
suggest that the incidence of endoleak is related to the length of
the landing zone?
4. All of the centers that were chosen for inclusion have a significant
amount of experience with the technique. Is there a learning curve?
How much experience did each of these centers have before begin-
ning the initiation of the registry? How is this technology diffused
out of the 13 centers in PERICLES?
5. And a final question. If you fast-forward a few years when the
competing technology fenestrated and branch grafts are Food and
Drug Administration–approved and readily available, will snorkel
and chimney grafts go away? Is this technique here transiently—to
bridge a gap—or will this approach be a viable option over the
long term? In other words, how, over the long term, do you think
these 2 approaches will stack up against each other?
Great effort. You and your coauthors are to be congratulated.
Response From J.T. Lee:
With regard to which type of conduit for the snorkel graft is
better or worse, we did perform subanalysis to look at risk factors for
both type Ia endoleak and renal patency.
There was a trend toward iCAST, which is a balloon-
expandable covered stent, having improved patency and less type
Ia endoleak, but this analysis is limited because of selection bias,
because we tend to use iCAST in the straighter renals versus the
self-expandable covered stent, the VIABAHN in more tortuous ap-
proaches to the branches. I suspect that if you controlled for anatomy
and branch angulation, there’s probably not a difference.
In terms of the main body endograft type influencing outcomes,
it’s always been my bias that using a device with suprarenal bare stents
to pin the snorkel graft up against the sidewall was favorable. This
seemed to come out in this registry because 70% of the worldwide
cases tended to be with the Endurant and Zenith device, which both
have suprarenal stents. In the univariate analysis of type Ia endoleaks,
we actually did note that infrarenal devices didn’t perform as well,
but that did not stand up in the multivariate analysis.
With regard to endoleak rates and the arbitrary 20 mm of neck,
we and other authors have chosen that on the basis of observation.
Subanalysis did not find a difference with and without type Ia en-
doleak (22-mm snorkel length vs 24), but intuitively, a longer seal
zone will likely have better long-term durability as with any endovas-
cular strategy.
Learning the procedure is an interesting question, as I think
this approach is slightly easier than the fenestrated approach simply
due to cannulation of branches without first going through another
device/hole. Since the Food and Drug Administration approval of
fenestrated devices in the United States, I personally have shifted
toward a ratio of 2:1 of fenestrated to the snorkel/chimney technique,
reserving this technique for urgent cases, when angulated anatomy
makes fenestrated grafts more challenging to line up, and difficult
iliac access. Diffusion of the snorkel/chimney technique has already
occurred, as many centers are offering this approach as an off-the-
shelf solution, and this registry confirms the effectiveness of the
procedure.
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Finally, I do believe that the technique is here to stay and not
just a transient bridge toward future technology. The skills obtained
during learning snorkel/chimney procedures will translate well to
future branched and thoracoabdominal pathology and new devices
forthcoming.
DISCUSSANTS
L.D. Britt (Norfolk, VA):
As a nonvascular surgeon, I fully appreciate and accept the
epidemic expansion in the endoluminal stents. I would remain in
my seat quiet until the last slide that you highlighted, whether the
procedure is durable. Do we really have the data as far as long-term
durability? As we put these grafts in younger and younger people and
people live longer and longer, I’m concerned about durability, which
you said that we have obviously met that, and I’m not sure that the
data will support that.
Response From J.T. Lee:
Durability, obviously, is in the eye of the beholder. I strongly
believe that we have shown midterm up to 2– or 3–year experience
in the published literature now with these devices and this approach.
I personally have patients now nearly 6 years out with excellent sac
exclusion and renal patency. I accept your critique that open surgery
has 10-year durability, but it is registries such as this that will hope-
fully help us provide this type of long-term durability for adequate
comparison to other surgical approaches.
DISCUSSANTS
J. Matsumura (Madison, WI):
I have 2 questions.
One, I ask all the fenestrated groups: how many patients died
waiting for the device or waiting to be scheduled? If we are treating
people with large aneurysms that have annual 15% chance of rupture,
and they have to wait 2 months, we may see ruptures. I have had
patients waiting who rupture and die. I don’t think we include that all
the time. Were waiting deaths included?
The second question is how did you pick whom to include
in the registry? You may have picked Mario and Frank because you
know they publish, but how did you look for possible sites that may
not have such good results? Have you kind of skimmed the cream?
Response From J.T. Lee:
I think the waiting time when using the currently approved
Food and Drug Administration–approved fenestrated device is one
of the advantages of the snorkel/chimney technique because there is
no delay. You can do this completely off-the-shelf for urgent cases,
and the Zurich group has shown this in its single-center series with
ruptured AAAs. Certainly, until we have an off-the-shelf fenestrated
device, which is probably 2 or 3 years away, we will see some ruptures
while awaiting scheduling or building of a custom device, which often
takes 3 to 5 weeks to build and ship.
With regard to putting the centers in the registry together, the
current registry authors met at a summit and performed an exhaustive
literature search and then contacted all of the sites that had more
than just case reports. We are all victims of publication bias, and it
is likely that this procedure has been written about by centers with a
reasonable outcome with this.
DISCUSSANTS
W. Quinones (Los Angeles, CA):
My question is related to both the literature and our experience,
suggesting that the number of snorkels per case has an impact on the
type Ia endoleaks. Did you look at that in this registry, and, if so,
what is your recommendation? What is the maximum number? Two?
Three? Four?
Response From J.T. Lee:
We agree that the more snorkel/chimneys, the increasing risk
for gutter type Ia endoleak. Basically, 1 snorkel graft works nearly
perfectly every time, with minimal displacement of the main body
endograft and a good seal. For us, 2 is probably the maximum that the
approach consistently works well. When we’ve ventured into using 3
or 4 snorkels, you need to consider right-sided arm access, conduit
placement in the left arm, increasing stroke issues, and need for longer
snorkel grafts. In our series and others, the overall complication rate
with 3 and 4 was higher both in the immediate term and in the follow–
up compared to 1 or 2 snorkels.
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